International Journal of Chronic Diseases / 2014 / Article / Tab 3

Clinical Study

Evaluation of Rhubarb Supplementation in Stages 3 and 4 of Chronic Kidney Disease: A Randomized Clinical Trial

Table 3

Comparison of adverse drug reactions (ADRs) between control and Rhubarb group.

Serial
number
ADR recordedControl
()
Rhubarb
()
Significance
(2-tailed)

1Nausea540.494
2Vomiting 430.442
3Diarrhea 530.275
4Constipation 010.497
5Anorexia 420.719
6Excessive thirst 010.245
7Abdominal pain111.000
8Muscle and joint pain 011.000
9Headache320.366
10Rashes 021.000
11Altered taste 011.000
12Weakness 100.497
13Frequent urination 021.000

was considered significant. Fisher’s exact test was applied.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.